跳至主要内容
临床试验/CTRI/2023/10/058529
CTRI/2023/10/058529招募中3 期

EUS-guided Versus Percutaneous Ultrasound-guided Biopsy for Parenchymal Liver Disease: A Randomized Controlled, Non-inferiority Trial - NI

Institute of Liver and Biliary Sciences0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Patients > 18 years of age.
  • 2.Eligibility for deep sedation with propofol.
  • 3.Undergoing liver biopsy for diagnosis/evaluation/staging.

排除标准

  • 1.Coagulopathy, defined by platelet count < 70,000/mL and/or INR > 1.7.
  • 2.Inability to discontinue anticoagulation or antiplatelet agents for 5 days prior to the procedure.
  • 3.Presence of unrelieved biliary obstruction.
  • 4.Presence of ascites.
  • 5.Suspected or known hepatic malignancy.
  • 6.Hypertensive patients with uncontrolled blood pressure. (SBP >150 and/or DBP >100mmHg)
  • 7.Medically unfit for sedation.
  • 8.Inability to provide informed consent.
  • 9.Cannot understand Hindi or English should be excluded since they will not be able to reply objectively to questionnaire.

研究者

相似试验